Characterization of ZC3H15 as a potential TRAF-2-interacting protein implicated in the NFκB pathway and overexpressed in AML

International Journal of Oncology

Volumn 43, Issue 1, 2013, Pages 246-254

  Capalbo, Gianni ^a   Mueller Kuller, Thea ^a   Koschmieder, Steffen ^b   Klein, Hans Ulrich ^c   Ottmann, Oliver G ^a   Hoelzer, Dieter ^a   Scheuring, Urban J ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Acute myeloid leukemia; Gene expression; LEREPO4; Microarray analysis; Zinc finger CCCH type containing 15

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; ZINC FINGER CCCH TYPE CONTAINING 15 PROTEIN; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL ADHESION; CELL CYCLE ARREST; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL;

APOPTOSIS; CARRIER PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; NF-KAPPA B; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2;

EID: 84879663659     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1924     Document Type: Article

References (17)

1. Strausberg RL, Feingold EA, Grouse LH, et al: Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA 99: 16899-16903, 2002. (Pubitemid 36034070)
2. Gregory RC, Lord KA, Panek LB, Gaines P, Dillon SB and Wojchowski DM: Subtraction cloning and initial characterization of novel epo-immediate response genes. Cytokine 12: 845-857, 2000. (Pubitemid 30479465)
3. Ishikawa K, Azuma S, Ikawa S, Semba K and Inoue J: Identification of DRG family regulatory proteins (DFRPs): specific regulation of DRG1 and DRG2. Genes Cells 10: 139-150, 2005. (Pubitemid 40287517)
4. Capalbo G, Muller-Kuller T, Dietrich U, Hoelzer D, Ottmann OG and Scheuring UJ: Inhibition of X4-tropic HIV type 1 replication by knockdown of the cellular protein LEREPO4. AIDS Res Hum Retroviruses 26: 1155-1161, 2010.
5. Scheuring UJ, Pfeifer H, Wassmann B, et al: Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl- positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571). Blood 101: 85-90, 2003. (Pubitemid 36025891)
6. Hebestreit K, Gröttrup S, Emden D, et al: Leukemia gene atlas - a public platform for integrative exploration of genome-wide molecular data. PLoS One 7: e39148, 2012.
7. Haferlach T, Kohlmann A, Wieczorek L, et al: Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol 28: 2529-2537, 2010.
8. Verhaak RG, Wouters BJ, Erpelinck CA, et al: Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica 94: 131-134, 2009.
9. Inoue J, Ishida T, Tsukamoto N, et al: Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp Cell Res 254: 14-24, 2000. (Pubitemid 30066727)
10. Mahajan MA, Park ST and Sun XH: Association of a novel GTP binding protein, DRG, with TAL oncogenic proteins. Oncogene 12: 2343-2350, 1996. (Pubitemid 26192714)
11. Leipe DD, Wolf YI, Koonin EV and Aravind L: Classification and evolution of P-loop GTPases and related ATPases. J Mol Biol 317: 41-72, 2002. (Pubitemid 34722199)
12. Bradley JR and Pober JS: Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20: 6482-6491, 2001. (Pubitemid 32977853)
13. Dempsey PW, Doyle SE, He JQ and Cheng G: The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 14: 193-209, 2003. (Pubitemid 36693141)
14. Schulze-Luehrmann J and Ghosh S: Antigen-receptor signaling to nuclear factor kappa B. Immunity 25: 701-715, 2006. (Pubitemid 46107295)
15. Bubici C, Papa S, Dean K and Franzoso G: Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 25: 6731-6748, 2006. (Pubitemid 44657849)
16. Cristobal I, Garcia-Orti L, Cirauqui C, Alonso MM, Calasanz MJ and Odero MD: PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect. Leukemia 25: 606-614, 2011.
17. Yang Y, Huang Q, Lu Y, Li X and Huang S: Reactivating PP2A by FTY720 as a novel therapy for AML with C-KIT tyrosine kinase domain mutation. J Cell Biochem 113: 1314-1322, 2012.